Prelude Capital Management’s X4 Pharmaceuticals XFOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-3,503
| Closed | -$70.3K | – | 1476 |
|
|
2024
Q3 | $70.3K | Sell |
3,503
-1,943
| -36% | -$39K | ﹤0.01% | 1087 |
|
|
2024
Q2 | $94.8K | Buy |
+5,446
| New | +$94.8K | 0.01% | 1009 |
|
|
2020
Q4 | – | Sell |
-64
| Closed | -$13K | – | 1624 |
|
|
2020
Q3 | $13K | Buy |
64
+61
| +2,033% | +$12.4K | ﹤0.01% | 1070 |
|
|
2020
Q2 | $1K | Buy |
+3
| New | +$1K | ﹤0.01% | 1271 |
|
|
2020
Q1 | – | Sell |
-7
| Closed | -$2K | – | 1631 |
|
|
2019
Q4 | $2K | Buy |
+7
| New | +$2K | ﹤0.01% | 1346 |
|